Cargando…

Replacing nebulizers by MDI-spacers for bronchodilator and inhaled corticosteroid administration: Impact on the utilization of hospital resources

BACKGROUND AND OBJECTIVES: Metered-dose inhalers plus spacers (MDI-spacer) are as effective as, or better than, nebulizers in aerosol delivery. The selection of aerosol delivery system for hospitalized children can have a significant impact on the utilization of healthcare resources. DESIGN AND SETT...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alhaider, S.A., Alshehri, H.A., Al-Eid, K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	King Faisal Specialist Hospital & Research Centre (General Organization), Saudi Arabia. Production and hosting by Elsevier B.V. 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104032/ https://www.ncbi.nlm.nih.gov/pubmed/32289071 http://dx.doi.org/10.1016/j.ijpam.2014.09.002

Ejemplares similares

The role of inhaled and/or nasal corticosteroids on the bronchodilator response
por: Lee, Ju Kyung, et al.
Publicado: (2010)

Indigenous device for in circuit delivery of bronchodilator drugs through MDI
por: Singh, Balkar, et al.
Publicado: (2010)

Effect of allergic phenotype on treatment response to inhaled bronchodilators with or without inhaled corticosteroids in patients with COPD
por: Cheng, Shih-Lung, et al.
Publicado: (2017)

MDI or nebulization in moderate to severe COVID-19 disease with COPD: which one is better?
por: Chilkoti, Geetanjali T., et al.
Publicado: (2021)

Prescribing patterns of nebulized bronchodilators: A prospective chart review
por: Yaxley, Julian P.
Publicado: (2016)

Systematic Review of Inhaled Bronchodilator and Corticosteroid Therapies in Infants with Bronchopulmonary Dysplasia: Implications and Future Directions
por: Clouse, Brian J., et al.
Publicado: (2016)

Long-acting bronchodilators with or without inhaled corticosteroids and 30-day readmission in patients hospitalized for COPD
por: Bishwakarma, Raju, et al.
Publicado: (2017)

Inhaled Bronchodilators and Corticosteroids in the Management of Bronchiolitis Obliterans due to Allogenic Hematopoietic Stem Cell Transplantation
por: Georgakopoulou, Vasiliki Epameinondas, et al.
Publicado: (2022)

Inhalation of Nebulized Fluids
Publicado: (1866)

Bronchodilator response after two methods of salbutamol nebulization in asthmatic children
por: Emeryk, Andrzej, et al.
Publicado: (2022)

Health resource utilization for inpatients with COPD treated with nebulized arformoterol or nebulized formoterol
por: Ganapathy, Vaidyanathan, et al.
Publicado: (2017)

Effects on Resource Utilization of Adding Salmeterol in Combination or Separately to Inhaled Corticosteroids
por: Chan, James, et al.
Publicado: (2007)

Pembrolizumab-associated bronchiolitis in an elderly lung cancer patient required the treatment with an inhaled corticosteroid, erythromycin and bronchodilators
por: Yamaya, Takafumi, et al.
Publicado: (2019)

A Pooled Analysis of Mortality in Patients with COPD Receiving Dual Bronchodilation with and without Additional Inhaled Corticosteroid
por: Miravitlles, Marc, et al.
Publicado: (2022)

Cardiovascular morbidity and the use of inhaled bronchodilators
por: Macie, Christine, et al.
Publicado: (2008)

Nasal high-flow bronchodilator nebulization: a randomized cross-over study
por: Reminiac, François, et al.
Publicado: (2018)

Revefenacin: A Once-Daily, Long-Acting Bronchodilator For Nebulized Treatment Of COPD
por: Donohue, James F, et al.
Publicado: (2019)

Evaluation of systemic absorption and bronchodilator effect of glycopyrronium bromide delivered by nebulizer or a dry powder inhaler in subjects with chronic obstructive pulmonary disease
por: Leaker, Brian R., et al.
Publicado: (2019)

Early response to inhaled bronchodilators and corticosteroids as a predictor of 12-month treatment responder status and COPD exacerbations
por: Calverley, Peter M, et al.
Publicado: (2016)

Inhaled Bronchodilator Use for Infants with Bronchopulmonary Dysplasia
por: Slaughter, Jonathan L, et al.
Publicado: (2014)

Barriers and supports to implementation of MDI/spacer use in nine Canadian pediatric emergency departments: a qualitative study
por: Scott, Shannon D, et al.
Publicado: (2009)

Which patients with chronic obstructive pulmonary disease benefit from the addition of an inhaled corticosteroid to their bronchodilator? A cluster analysis
por: DiSantostefano, Rachael L, et al.
Publicado: (2013)

Impact of long-term treatment with inhaled corticosteroids and bronchodilators on lung function in a patient with post-infectious bronchiolitis obliterans
por: Calabrese, Cecilia, et al.
Publicado: (2016)

A Pilot Study of Nebulized Heparin for Prevention of Ventilator Induced Lung Injury: Comparative Effects with an Inhaled Corticosteroid
por: Ghiasi, Farzin, et al.
Publicado: (2017)

Nebulized corticosteroids in the management of acute exacerbation of COPD
por: Gaude, G. S., et al.
Publicado: (2010)

Effect of MDI Actuation Timing on Inhalation Dosimetry in a Human Respiratory Tract Model
por: Talaat, Mohamed, et al.
Publicado: (2022)

Utilization of Inhaled Corticosteroids for Infants with Bronchopulmonary Dysplasia
por: Slaughter, Jonathan L., et al.
Publicado: (2014)

CLIC MDI Overview
por: Gatignon, Lau
Publicado: (2012)

CLIC MDI Overview
por: Gatignon, Lau
Publicado: (2012)

Comparison of resource use by COPD patients on inhaled therapies with long-acting bronchodilators: a database study
por: Kozma, Chris M, et al.
Publicado: (2011)

What makes flunisolide different among inhaled corticosteroids used for nebulization: a close look at the role of aqueous solubility
por: Kantar, Ahmad
Publicado: (2021)

Inhalation Pneumonitis Caused by Nebulized Hydrogen Peroxide
por: Manfra, Andrew, et al.
Publicado: (2023)

High strength extrafine pMDI beclometasone/formoterol (200/6 μg) is effective in asthma patients not adequately controlled on medium-high dose of inhaled corticosteroids
por: Paggiaro, Pierluigi, et al.
Publicado: (2016)

Adherence to current guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of long-acting bronchodilators or inhaled corticosteroids
por: Asche, Carl Victor, et al.
Publicado: (2012)

Bronchodilator delivery with metered-dose inhaler during mechanical ventilation
por: Georgopoulos, Dimitris, et al.
Publicado: (2000)

Inhaled bronchodilator exposure in the management of bronchopulmonary dysplasia in hospitalized infants
por: Euteneuer, Joshua C., et al.
Publicado: (2020)

COMPARISON OF TWO INHALATIONAL TECHNIQUES FOR BRONCHODILATOR ADMINISTRATION IN CHILDREN AND ADOLESCENTS WITH ACUTE ASTHMA CRISIS: A META-ANALYSIS
por: Roncada, Cristian, et al.
Publicado: (2018)

(Selected) MDI Issues of ILD
por: Pöschl, Roman
Publicado: (2020)

MDI Experience from the ILC
por: Buesser, Karsten
Publicado: (2007)

Bronchodilators, Antibiotics, and Oral Corticosteroids Use in Primary Care for Children With Cough
por: Krishnan, Sankaran, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ldk9kj9ldpgifv0tnisq9gcd4d